Glucose-6-phosphate dehydrogenase Velletri.

Area of Science:

• Biochemistry
• Hematology
• Enzymology

Background:

• Congenital non-spherocytic hemolytic anemia (CNSHA) is a group of inherited red blood cell disorders.
• Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic disorder that can lead to hemolytic anemia.
• Understanding G6PD variants is crucial for diagnosing and managing hemolytic anemias.

Observation:

• A new variant of red cell glucose-6-phosphate dehydrogenase (G6PD) was identified in a Caucasian patient with CNSHA.
• The identified G6PD variant displayed reduced enzyme activity and increased thermolability.
• Biochemical analysis revealed altered kinetic parameters, including increased Michaelis constants for substrates and a biphasic pH-activity profile.

Findings:

• The novel G6PD variant exhibits significantly reduced catalytic activity.
• Increased thermolability suggests enzyme instability at physiological temperatures.
• Altered Michaelis constants indicate impaired substrate binding or catalytic efficiency.
• The biphasic pH-activity profile points to complex regulatory mechanisms or structural changes.

Implications:

• This discovery expands the known spectrum of G6PD deficiency variants.
• Characterization of this variant aids in understanding the molecular basis of CNSHA.
• The findings may inform diagnostic strategies and genetic counseling for patients with unexplained hemolytic anemia.
• The compensatory increase in NADP-glutathione reductase highlights cellular adaptive responses to G6PD deficiency.